aegean trial: perioperative durvalumab for nsclc - onctalk lung 2023
Published 6 months ago • 121 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
2:22
neotorch trial: perioperative toripalimab for nsclc - onctalk lung 2023
-
2:12
neoadjuvant, perioperative, adjuvant: defining terms and advantages - onctalk lung 2023
-
1:57
keynote 091: adjuvant pembrolizumab - onctalk lung 2023
-
1:48
preoperative or postoperative immunotherapy? - lung cancer onctalk 2022
-
6:38
asco 2021 lung recap: poseidon trial: durvalumab /- tremelimumab vs. chemo alone
-
6:06
the adaura trial: the effect on egfr treatment - targeted therapies in lung cancer 2023
-
2:13
lung cancer video library - immunotherapy in stage lll nsclc - the pacific trial and imfinzi
-
5:54
key points from the adaura trial: osimertinib - targeted therapies in lung cancer 2023
-
4:12
trials for patients with actionable mutations, & the importance of quality of life - onctalk 2022
-
3:21
bispecific antibodies: amivantamab - onctalk lung 2023
-
5:18
clinical trials 101: what are phases and types of trials? - patient education ambassadors 2023-24
-
1:55
how do i find clinical trials? - blood cancer onctalk
-
2:11
neoadjuvant osimertinib and surgically resectable egfr - targeted therapies in lung cancer 2023
-
4:19
clinical trial spotlight: alchemist for early-stage alk and egfr lung cancer patients
-
2:21
ret fusion treatment: pralsetinib - targeted therapies in lung cancer 2023
-
8:43
selpercatinib and pralsetinib in ret disease - lung cancer video library
-
12:58
egfr inhibitor therapy in second line